Oncolys BioPharma Market Cap

Oncolys BioPharma has a market cap or net worth of 73.59 billion as of June 2, 2026. Its market cap has increased by 423.94% in one year.

Market Cap

73.59B

Enterprise Value

70.78B

Revenue

28.55M

Ranking

n/a

PE Ratio

n/a

Stock Price

2,532.00

Market Cap Chart

Since December 6, 2013, Oncolys BioPharma's market cap has increased from 23.62B to 73.59B, an increase of 211.60%. That is a compound annual growth rate of 9.52%.

Market Cap History

Date	Market Cap	% Change
Jun 2, 2026	73.59B	85.90%
Dec 30, 2025	39.59B	207.33%
Dec 30, 2024	12.88B	18.41%
Dec 29, 2023	10.88B	19.14%
Dec 30, 2022	9.13B	-0.44%
Dec 30, 2021	9.17B	-58.26%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
GNI Group	143.51B
Takara Bio	137.63B
PeptiDream	135.35B
SanBio Company	100.83B
Nxera Pharma	93.20B
Healios K.K.	44.01B
Cuorips	37.65B
Japan Tissue Engineering	24.69B

Market Cap Rankings